BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 18161485)

  • 1. Relaxin-family peptide and receptor systems in brain: insights from recent anatomical and functional studies.
    Ma S; Gundlach AL
    Adv Exp Med Biol; 2007; 612():119-37. PubMed ID: 18161485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relaxin-3, INSL5, and their receptors.
    Liu C; Lovenberg TW
    Results Probl Cell Differ; 2008; 46():213-37. PubMed ID: 18236022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic targeting of relaxin and insl3 signaling in mice.
    Feng S; Bogatcheva NV; Kamat AA; Agoulnik AI
    Ann N Y Acad Sci; 2005 May; 1041():82-90. PubMed ID: 15956690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coevolution of the relaxin-like peptides and their receptors.
    Wilkinson TN; Speed TP; Tregear GW; Bathgate RA
    Ann N Y Acad Sci; 2005 May; 1041():534-9. PubMed ID: 15956757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relaxin, the relaxin-like factor and their receptors.
    Schwabe C; Büllesbach EE
    Adv Exp Med Biol; 2007; 612():14-25. PubMed ID: 18161478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relaxin-3/insulin-like peptide 5 chimeric peptide, a selective ligand for G protein-coupled receptor (GPCR)135 and GPCR142 over leucine-rich repeat-containing G protein-coupled receptor 7.
    Liu C; Chen J; Kuei C; Sutton S; Nepomuceno D; Bonaventure P; Lovenberg TW
    Mol Pharmacol; 2005 Jan; 67(1):231-40. PubMed ID: 15465925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The evolution of the relaxin peptide family and their receptors.
    Wilkinson TN; Bathgate RA
    Adv Exp Med Biol; 2007; 612():1-13. PubMed ID: 18161477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. R3(BDelta23 27)R/I5 chimeric peptide, a selective antagonist for GPCR135 and GPCR142 over relaxin receptor LGR7: in vitro and in vivo characterization.
    Kuei C; Sutton S; Bonaventure P; Pudiak C; Shelton J; Zhu J; Nepomuceno D; Wu J; Chen J; Kamme F; Seierstad M; Hack MD; Bathgate RA; Hossain MA; Wade JD; Atack J; Lovenberg TW; Liu C
    J Biol Chem; 2007 Aug; 282(35):25425-35. PubMed ID: 17606621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. International Union of Pharmacology LVII: recommendations for the nomenclature of receptors for relaxin family peptides.
    Bathgate RA; Ivell R; Sanborn BM; Sherwood OD; Summers RJ
    Pharmacol Rev; 2006 Mar; 58(1):7-31. PubMed ID: 16507880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relaxin family peptides and their receptors.
    Bathgate RA; Halls ML; van der Westhuizen ET; Callander GE; Kocan M; Summers RJ
    Physiol Rev; 2013 Jan; 93(1):405-80. PubMed ID: 23303914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relaxin family peptide systems and the central nervous system.
    Callander GE; Bathgate RA
    Cell Mol Life Sci; 2010 Jul; 67(14):2327-41. PubMed ID: 20213277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. G-protein-coupled receptor (GPCR)-142 does not contribute to relaxin-3 binding in the mouse brain: further support that relaxin-3 is the physiological ligand for GPCR135.
    Sutton SW; Bonaventure P; Kuei C; Nepomuceno D; Wu J; Zhu J; Lovenberg TW; Liu C
    Neuroendocrinology; 2005; 82(3-4):139-50. PubMed ID: 16679775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the mouse and rat relaxin receptors.
    Scott DJ; Layfield S; Riesewijk A; Morita H; Tregear GW; Bathgate RA
    Ann N Y Acad Sci; 2005 May; 1041():8-12. PubMed ID: 15956680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative localization of leucine-rich repeat-containing G-protein-coupled receptor-7 (RXFP1) mRNA and [33P]-relaxin binding sites in rat brain: restricted somatic co-expression a clue to relaxin action?
    Ma S; Shen PJ; Burazin TC; Tregear GW; Gundlach AL
    Neuroscience; 2006 Aug; 141(1):329-44. PubMed ID: 16725278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relaxin-3: improved synthesis strategy and demonstration of its high-affinity interaction with the relaxin receptor LGR7 both in vitro and in vivo.
    Bathgate RA; Lin F; Hanson NF; Otvos L; Guidolin A; Giannakis C; Bastiras S; Layfield SL; Ferraro T; Ma S; Zhao C; Gundlach AL; Samuel CS; Tregear GW; Wade JD
    Biochemistry; 2006 Jan; 45(3):1043-53. PubMed ID: 16411781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Membrane receptors: structure and function of the relaxin family peptide receptors.
    Kong RC; Shilling PJ; Lobb DK; Gooley PR; Bathgate RA
    Mol Cell Endocrinol; 2010 May; 320(1-2):1-15. PubMed ID: 20138959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-relaxin family peptide signaling and receptors in mouse brain membranes and neuronal cells.
    Ortinau S; Lin F; Wade JD; Tregear GW; Bathgate RA; Gundlach AL
    Ann N Y Acad Sci; 2005 May; 1041():211-5. PubMed ID: 15956710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple binding sites revealed by interaction of relaxin family peptides with native and chimeric relaxin family peptide receptors 1 and 2 (LGR7 and LGR8).
    Halls ML; Bond CP; Sudo S; Kumagai J; Ferraro T; Layfield S; Bathgate RA; Summers RJ
    J Pharmacol Exp Ther; 2005 May; 313(2):677-87. PubMed ID: 15649866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent progress in relaxin-3-related research.
    Liu C; Bonaventure P; Sutton SW; Chen J; Kuei C; Nepomuceno D; Lovenberg TW
    Ann N Y Acad Sci; 2005 May; 1041():47-60. PubMed ID: 15956687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolution of the signaling system in relaxin-family peptides.
    Hsu SY; Semyonov J; Park JI; Chang CL
    Ann N Y Acad Sci; 2005 May; 1041():520-9. PubMed ID: 15956755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.